Truist Securities Maintains Buy on Laboratory Corp, Lowers Price Target to $270
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Ryan MacDonald has maintained a 'Buy' rating on Laboratory Corp (NYSE:LH) but lowered the price target from $275 to $270.
July 28, 2023 | 2:41 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has maintained a 'Buy' rating on Laboratory Corp but lowered the price target from $275 to $270.
The news is directly related to Laboratory Corp and is important for investors as it provides an updated price target from a reputable analyst. However, the impact on the stock price is neutral in the short term as the 'Buy' rating is maintained despite a slight decrease in the price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100